0 members (),
680
guests, and
32
robots. |
Key:
Admin,
Global Mod,
Mod
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
There are no members with birthdays on this day. |
SPC MD 707
by Webmaster - Wed 08 May 2024 09:56:PM
|
SPC MD 708
by Webmaster - Wed 08 May 2024 09:56:PM
|
SPC MD 709
by Webmaster - Wed 08 May 2024 09:56:PM
|
SPC MD 710
by Webmaster - Wed 08 May 2024 09:56:PM
|
SPC MD 705
by Webmaster - Wed 08 May 2024 09:56:PM
|
|
|
|
|
|
#217509
Thu 17 Apr 2014 04:41:PM
|
Joined: Feb 2001
Posts: 381,903
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,903 |
Analysis of 20 years’ worth of patient data shows that outcomes have clearly improved for patients suffering from advanced cancer of the abdomen when treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy, or HIPEC. Cytoreductive surgery, or debulking, is removal of part of a malignant tumor which can't be completely excised and is done to enhance chemotherapy effectiveness. HIPEC is a perfusion technique in which heated chemotherapy is administered directly into the abdomen during the surgery to kill remaining cancer cells. Source: 20 years of data shows treatment technique improvement for advanced abdominal cancer
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
Forums60
Topics685,665
Posts720,276
Members2,957
|
Most Online3,142 Jan 16th, 2023
|
|
|